Kin Wah Chew, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-6152 Fax: 410-328-3758 |
Zachary Obinna Enumah, Surgery Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Tower 110, Baltimore, MD 21287 Phone: 410-955-5000 |
Nicholas Robert Mahoney, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-1112 Fax: 410-614-9987 |
Mr. Alistair Juel Kent, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Zayed Suite 6107, Baltimore, MD 21287 Phone: 410-955-5000 |
Dr. Areck A Ucuzian, M.D., PH.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St # S10b00, University Of Maryland Medical Center, Baltimore, MD 21201 Phone: 410-328-5840 |
Meaghan Broderick, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 914-843-5165 |
Edward C Mccarron, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9103 Franklin Square Dr, Suite 2200, Baltimore, MD 21237 Phone: 443-777-7911 |
Christine Lynn Lau, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-6019 Fax: 410-706-6976 |
Dr. Alfred John Casillan, MD, PHD Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-614-3892 Fax: 410-500-4248 |
Luke Kenneth Dombert, MD Surgery Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-9441 |
Makayla Marie Coan, PA-C Surgery Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-502-2651 |
Dr. Joel A Turner, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 6535 N Charles St, Suite 510, Baltimore, MD 21204 Phone: 410-821-6260 Fax: 410-296-6936 |
Thomas J Swope, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 Saint Paul Pl, Pob 912, Baltimore, MD 21202 Phone: 410-332-9653 Fax: 410-783-5888 |
Mark Douglas Duncan, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Baltimore, MD 21224 Phone: 410-550-0400 |
Nevin Margolis Katz, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1800 Orleans St, Suite 7107, Baltimore, MD 21287 Phone: 443-287-0566 |
Dr. Nagarjun Rayapudi, M.D Surgery Medicare: Not Enrolled in Medicare Practice Location: 103 E Mount Royal Ave, Apt 305, Baltimore, MD 21202 Phone: 130-925-8396 |
Dr. Helena Marie Crowley, MD PHD Surgery Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-5730 |
Brandon Michael White, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1800 Orleans St # 110, Baltimore, MD 21287 Phone: 410-955-5020 |
Dr. Richard N. Pierson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-6897 Fax: 410-328-2109 |
Gary Thomas Schwartzbauer, MD Surgery - Surgical Critical Care Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-5262 |
News Archive
Chaperone protein imbalance can play a significant role in initiating toxic accumulation of tau in the aging brain - an early step in the development of Alzheimer's disease and related neurodegenerative disorders known as tauopathies, a new preclinical study by University of South Florida Health (USF Health) neuroscientists suggests.
Trius Therapeutics, Inc. announced that the first patient has been dosed in its Phase 3 clinical study of the oral dosage form of torezolid phosphate for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The double-blind, active control, pivotal study is designed to compare the efficacy and safety of once-daily oral administration of 200 milligrams of torezolid phosphate for six days of treatment with the efficacy and safety of twice-daily oral administration of 600 milligrams of linezolid (Zyvox®) for 10 days of treatment.
Inspire Pharmaceuticals, announced today financial results for the fourth quarter and year ended December 31, 2010. For the quarter ended December 31, 2010, the Company reported a net loss of $4.3 million, or per common share, compared to a net loss of $2.6 million, or per common share, for the same period in 2009.
A small tropical fish, the curiosity of a Geisinger research scientist and some college students have created the perfect storm of sorts in an attempt to find a cure for one of the world's most devastating neurological diseases.
› Verified 6 days ago